These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36675271)

  • 1. AmyP53 Prevents the Formation of Neurotoxic β-Amyloid Oligomers through an Unprecedent Mechanism of Interaction with Gangliosides: Insights for Alzheimer's Disease Therapy.
    Azzaz F; Chahinian H; Yahi N; Fantini J; Di Scala C
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy Strategy for Alzheimer's and Parkinson's Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells.
    El-Battari A; Rodriguez L; Chahinian H; Delézay O; Fantini J; Yahi N; Di Scala C
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer's and Parkinson's Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery.
    Di Scala C; Armstrong N; Chahinian H; Chabrière E; Fantini J; Yahi N
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?
    Fantini J; Chahinian H; Yahi N
    Protein Sci; 2020 Aug; 29(8):1748-1759. PubMed ID: 32567070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides.
    Di Scala C; Yahi N; Flores A; Boutemeur S; Kourdougli N; Chahinian H; Fantini J
    Biochim Biophys Acta; 2016 Feb; 1862(2):213-22. PubMed ID: 26655601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson's disease.
    Yahi N; Di Scala C; Chahinian H; Fantini J
    Glycoconj J; 2022 Feb; 39(1):1-11. PubMed ID: 34328594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the glycolipid code of Alzheimer's and Parkinson's amyloid proteins allowed the creation of a universal ganglioside-binding peptide.
    Yahi N; Fantini J
    PLoS One; 2014; 9(8):e104751. PubMed ID: 25140899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Visualization of amyloid formation processes on cell membranes: gangliosides as key molecules for the onset of amyloidosis].
    Wakabayashi M
    Yakugaku Zasshi; 2010 Oct; 130(10):1295-303. PubMed ID: 20930481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the binding kinetics and behaviors of self-aggregated beta-amyloid oligomers to phase-separated lipid rafts with or without ganglioside-clusters.
    Pham T; Cheng KH
    Biophys Chem; 2022 Nov; 290():106874. PubMed ID: 36067650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The binding of Aβ1-42 to lipid rafts of RBC is enhanced by dietary docosahexaenoic acid in rats: Implicates to Alzheimer's disease.
    Hashimoto M; Hossain S; Katakura M; Al Mamun A; Shido O
    Biochim Biophys Acta; 2015 Jun; 1848(6):1402-9. PubMed ID: 25782726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases.
    Marin R; Fabelo N; Martín V; Garcia-Esparcia P; Ferrer I; Quinto-Alemany D; Díaz M
    Neurobiol Aging; 2017 Jan; 49():52-59. PubMed ID: 27768960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common molecular mechanism of amyloid pore formation by Alzheimer's β-amyloid peptide and α-synuclein.
    Di Scala C; Yahi N; Boutemeur S; Flores A; Rodriguez L; Chahinian H; Fantini J
    Sci Rep; 2016 Jun; 6():28781. PubMed ID: 27352802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid.
    Kakio A; Nishimoto S; Yanagisawa K; Kozutsumi Y; Matsuzaki K
    Biochemistry; 2002 Jun; 41(23):7385-90. PubMed ID: 12044171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ganglioside cluster-mediated aggregation and cytotoxicity of amyloid beta-peptide: molecular mechanism and inhibition].
    Matsuzaki K
    Yakugaku Zasshi; 2010 Apr; 130(4):511-5. PubMed ID: 20371994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A protective role for lipid raft cholesterol against amyloid-induced membrane damage in human neuroblastoma cells.
    Cecchi C; Nichino D; Zampagni M; Bernacchioni C; Evangelisti E; Pensalfini A; Liguri G; Gliozzi A; Stefani M; Relini A
    Biochim Biophys Acta; 2009 Oct; 1788(10):2204-16. PubMed ID: 19651105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores.
    Arbor SC; LaFontaine M; Cumbay M
    Yale J Biol Med; 2016 Mar; 89(1):5-21. PubMed ID: 27505013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal membranes are key to the pathogenesis of Alzheimer's disease: the role of both raft and non-raft membrane domains.
    Williamson R; Sutherland C
    Curr Alzheimer Res; 2011 Mar; 8(2):213-21. PubMed ID: 21222605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-β Interactions with Lipid Rafts in Biomimetic Systems: A Review of Laboratory Methods.
    Staneva G; Watanabe C; Puff N; Yordanova V; Seigneuret M; Angelova MI
    Methods Mol Biol; 2021; 2187():47-86. PubMed ID: 32770501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural transitions associated with the interaction of Alzheimer beta-amyloid peptides with gangliosides.
    McLaurin J; Franklin T; Fraser PE; Chakrabartty A
    J Biol Chem; 1998 Feb; 273(8):4506-15. PubMed ID: 9468505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological significance of ganglioside clusters in Alzheimer's disease.
    Yanagisawa K
    J Neurochem; 2011 Mar; 116(5):806-12. PubMed ID: 21214549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.